MedPath

Milrinone Lactate in Dextrose

Milrinone Lactate in 5% Dextrose Injection (For Intravenous Use) Rx only

Approved
Approval ID

838da14b-c070-4c09-b088-99e7c64d9964

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 25, 2021

Manufacturers
FDA

Gland Pharma Limited

DUNS: 918601238

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Milrinone Lactate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68083-410
Application NumberANDA213585
Product Classification
M
Marketing Category
C73584
G
Generic Name
Milrinone Lactate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 25, 2021
FDA Product Classification

INGREDIENTS (5)

MILRINONE LACTATEActive
Quantity: 0.2 mg in 1 mL
Code: 9K8XR81MO8
Classification: ACTIM
LACTIC ACIDInactive
Quantity: 0.282 mg in 1 mL
Code: 33X04XA5AT
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
DEXTROSE MONOHYDRATEInactive
Quantity: 54.3 mg in 1 mL
Code: LX22YL083G
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Milrinone Lactate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68083-411
Application NumberANDA213585
Product Classification
M
Marketing Category
C73584
G
Generic Name
Milrinone Lactate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 25, 2021
FDA Product Classification

INGREDIENTS (5)

LACTIC ACIDInactive
Quantity: 0.282 mg in 1 mL
Code: 33X04XA5AT
Classification: IACT
DEXTROSE MONOHYDRATEInactive
Quantity: 54.3 mg in 1 mL
Code: LX22YL083G
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
MILRINONE LACTATEActive
Quantity: 0.2 mg in 1 mL
Code: 9K8XR81MO8
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.